Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
Who this might be right for
Glioma
Cerenome 55
Showing 16 of 16 results